⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
globenewswire.com
MRK
BMY
AMGN
OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting
globenewswire.com
MRK
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
globenewswire.com
TSEM
TAK
MRK
IONS
SLN
INCY
JNJ
VNDA
Global Lung Cancer Therapeutics Market to Reach USD 142.3 Billion as Precision Medicine and Immunotherapy Redefine Oncology Care | Future Market Insights
prnewswire.com
AZN
MRK
BMY
PFE
LLY
NVS
TAK
AMGN
AI in Drug Discovery Market to Reach USD 160.49 Billion, Rising at a 23.22% CAGR by 2035
globenewswire.com
AMZN
JNJ
NVS
SNY
AZN
PFE
GSK
MRNA
BMY
LLY
MRK
ABBV
Phanes Therapeutics to Present Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
prnewswire.com
MRK
Form 8-K
sec.gov
TENX
LNSR
BCRX
MRK
GILD
Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
prnewswire.com
MRK
GOOGL
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
prnewswire.com
LH
AGNC
MRK
Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca
globenewswire.com
MRK
BMY
AZN